Clinical Trial Update: A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients [Phase 3]

View source ↗

Summary

This document notes an ongoing Phase 3 therapeutic confirmatory trial comparing Epaminurad to Febuxostat in gout patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Epaminurad (Epaminurad)
• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Gout | Phase 3 | Status: ACTIVE_NOT_RECRUITING